Cargando…
Aptamer-Mediated Codelivery of Doxorubicin and NF-κB Decoy Enhances Chemosensitivity of Pancreatic Tumor Cells
Aptamers able to bind efficiently cell-surface receptors differentially expressed in tumor and in healthy cells are emerging as powerful tools to perform targeted anticancer therapy. Here, we present a novel oligonucleotide chimera, composed by an RNA aptamer and a DNA decoy. Our assembly is able to...
Autores principales: | Porciani, David, Tedeschi, Lorena, Marchetti, Laura, Citti, Lorenzo, Piazza, Vincenzo, Beltram, Fabio, Signore, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417125/ https://www.ncbi.nlm.nih.gov/pubmed/25919089 http://dx.doi.org/10.1038/mtna.2015.9 |
Ejemplares similares
-
Two Interconvertible Folds Modulate the Activity of a DNA Aptamer Against Transferrin Receptor
por: Porciani, David, et al.
Publicado: (2014) -
Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer
por: Li, Ke, et al.
Publicado: (2019) -
Aptamer-based gold nanoparticle aggregates for ultrasensitive amplification-free detection of PSMA
por: Matteoli, Giulia, et al.
Publicado: (2023) -
Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy
por: Jin, Xun, et al.
Publicado: (2016) -
Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
por: Zhang, Yi, et al.
Publicado: (2018)